Clinical Data, Inc. to Present at the JMP Securities Healthcare Conference
NEWTON, Mass.--([ BUSINESS WIRE ])--[ Clinical Data, Inc. ] (NASDAQ: CLDA), today announced that Drew Fromkin, President and Chief Executive Officer, will be presenting a corporate overview at the Fifth Annual JMP Securities Healthcare Conference on Monday, September 27, 2010 at the New York Palace Hotel, New York, NY. Clinical Dataa™s presentation will take place at 10:00 a.m. EDT.
A live audio and archived webcast of the Companya™s presentation can be accessed through Clinical Data's website at [ www.clda.com ].
About Clinical Data, Inc.
Clinical Data develops first-in-class and best-in-category therapeutics. The Company is advancing its late-stage drug candidates for [ central nervous system disorders ] and [ cardiovascular diseases ], to be followed by promising drug candidates in [ other major therapeutic areas ]. Clinical Data combines its drug development and biomarker expertise in an effort to develop products with enhanced efficacy and tolerability to improve patient health and reduce costs. To learn more, please visit the Company's website at [ www.clda.com ].